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Abstract
Background: We aimed to determine the accuracy of laser Doppler perfusion imaging (LDPI) in an animal model
for hind limb ischemia.
Methods: We used a murine (C57Bl/6 mice) ischemic hind limb model in which we compared LDPI with the
clinically used 99mTc-sestamibi SPECT perfusion imaging (n = 7). In addition, we used the SPECT tracer
99mTc-pyrophosphate (99mTc-PyP) to image muscular damage (n = 6).
Results: LDPI indicated a quick and prominent decrease in perfusion immediately after ligation, subsequently
recovering to 21.9 and 25.2 % 14 days later in the 99mTc-sestamibi and 99mTc-PyP group, respectively.
99mTc-sestamibi SPECT scans also showed a quick decrease in perfusion. However, nearly full recovery was reached
7 days post ligation. Muscular damage, indicated by the uptake of 99mTc-PyP, was highest at day 3 and recovered
to baseline levels at day 14 post ligation. Postmortem histology supported these findings, as a significantly
increased collateral diameter was found 7 and 14 days after ligation and peak macrophage infiltration and TUNEL
positivity was found on day 3 after ligation.
Conclusions: Here, we indicate that LDPI strongly underestimates perfusion recovery in a hind limb model for
profound ischemia.
Keywords: Laser Doppler perfusion imaging (LDPI), Single-photon emission computed tomography (SPECT), Hind
limb ischemia, Perfusion recovery, Overestimation of therapeutic window
Background
Numerous ischemic hind limb models have been devel-
oped in mice [1–10], rats [11, 12], and rabbits [1] in order
to study post-ligation perfusion recovery through neovas-
cularization. Most hind limb ischemia studies have been
conducted in mice and rats and regardless of the studied
mode of neovascularization (i.e., arteriogenesis or angio-
genesis), and follow-up of post-ligation perfusion recovery
is often performed by laser Doppler perfusion imaging
(LDPI) [2–6, 9, 10, 13, 14]. Other methods frequently used
in pre-clinical research for the assessment of post-ligation
perfusion recovery are angiography [3, 4, 9–11, 14, 15],
microsphere injections [2, 4, 11, 12, 15], contrast-
enhanced ultrasound [16], micro CT [10], and magnetic
resonance imaging (MRI) [14]. However, despite the var-
iety in methods to monitor perfusion recovery in the
ischemic hind limb, LDPI remains the most frequently
used. The main reasons are that LDPI is a fast, efficient,
and non-invasive technique to document extremity blood-
flow [17]. However, since LDPI is limited by the penetra-
tion depth of the laser light [8, 18], allowing measurement
of superficial skin perfusion only, the question arises
whether LDPI scanning is accurately reflecting the
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incremental perfusion improvement of skeletal muscles
through arteriogenesis in the upper hind limb or angio-
genesis in the lower hind limb of the animal.
Positron emission tomography (PET) and single-
photon emission computed tomography (SPECT) are
non-invasive and radioisotope-based nuclear imaging
techniques that can be used to image changes in tissue
blood flow, which can provide early, sensitive, and spe-
cific detection of ischemic diseases at the molecular level
[19, 20]. With increasing availability of better and dedi-
cated small animal cameras as well as the development
of new radiotracers, these nuclear imaging techniques
provide excellent tools for perfusion imaging.
Here, we used the SPECT perfusion tracer technetium-
99m sestamibi (99mTc-sestamibi) to study whether LDPI
accurately reflects perfusion recovery in a murine ische-
mic hind limb model for arteriogenesis. Additionally, we
used technetium-99m pyrophosphate (99mTc-PyP) as a
molecular tracer for muscular damage as it binds to hy-
droxyapatite crystals in damaged myocytes [21, 22]. Ac-
quired 3-dimensional (3D) information on perfusion and
myocyte damage provided by SPECT scans may prove to
be a useful addition to standardized pre-clinical perfusion
recovery analysis by LDPI.
Methods
Animal model
C57Bl/6 mice were anesthetized with isoflurane (1.5–2 %)
throughout the whole surgical procedure to induce hind
limb ischemia. Analgesia was applied 30 min before and
6 h after the procedure with Temgesic (0.5 mg/BW). In
short, a longitudinal incision was made in the skin overlying
the middle portion of the right hind limb of the mice. The
femoral artery was dissected for several millimeters in
length from the femoral nerve and femoral vein. The artery
was ligated proximal to the superficial epigastric artery by
electrocoagulation. Subsequently, the skin was closed with
a continued suture. Next, a longitudinal incision was made
in the skin just above the knee of the right hind limb. The
femoral artery was dissected for several millimeters in
length from the femoral nerve and femoral vein. The artery
was ligated distal from the bifurcation of the saphenous ar-
tery and the popliteal artery by electrocoagulation. Seven
C57Bl/6 mice were used in the 99mTc-sestamibi group, and
six C57Bl/6 mice were used in the 99mTc-PyP group.
Animals were held under the guidelines of the animal
care facility (Maastricht University) with unlimited ac-
cess to food and drinking water. All animal experiments
were approved by the Committee for Animal Welfare of
the Maastricht University conform the Directive 2010/
63/EU of the European Parliament.
Laser Doppler perfusion imaging
Under standardized conditions, blood flow in the hind
limbs of all animals was measured using LDPI (Moor In-
struments, UK). Measurements were performed 4 days
prior to the surgical procedure (baseline scan), directly
after the surgical procedure and at post-operative days 3,
7, and 14. During the measurements, mice were under
anesthesia (isoflurane: induction 2.5 %; maintenance
1.5 %) and placed on a heating pad in a climate con-
trolled chamber (37 °C) to ensure minimal variation be-
tween flow measurements. The perfusion ratio per time
point was calculated by dividing the perfusion of the li-
gated (ischemic) by the non-ligated (non-ischemic) hind
limb. Regions of interest (ROIs) were drawn manually
around the foot of the ischemic hind limb and the
contralateral non-ischemic foot (Fig. 1 baseline panel).
SPECT tracers
99mTc-sestamibi
99mTc-sestamibi was prepared from a lyophilized sestamibi
kit according to manufacturer guidelines (Mallinckrodt
Medical, Petten, The Netherlands). Quality controls were
satisfactory for every synthesis (radiochemical purity
>98 %). The activity was 59.8 ± 21.0 MBq (mean ± SD).
99mTc-pyrophosphate
Six milliliters of 0.9 % NaCl solution was added to the
lyophilized PyP-kit (Technescan PYP, Mallinckrodt Med-
ical, Petten, The Netherlands). One hundred fifty micro-
liters of the stannous ion containing PyP kit (10 times
diluted) was injected through a custom-made tail vein
catheter in order to reduce red blood cell-bound pro-
teins. Fifteen minutes post-stannous PyP injection,
freshly eluted pertechnetate (activity 55.5 ± 19.4 MBq,
mean ± SD) was injected through the same tail vein
Fig. 1 A typical representation of perfusion recovery in the mouse hind limb over time as can be seen by LDPI. A representative ROI placement
for LDPI is shown in the baseline panel
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catheter. In vivo formed 99mTc-stannous PyP binds to
hydroxyapatite crystals in damaged cells, thereby acting
as a molecular marker for cellular damage.
SPECT imaging
Imaging protocols
Mice were anesthetized with isoflurane (induction 2.5 %;
maintenance; 1.5 %), and a catheter was placed in the
tail vein and the animals were positioned in the micro-
SPECT camera (MiLabs, Utrecht, The Netherlands). Im-
aging of the mice in the 99mTc-sestamibi group and the
99mTc-pyrophosphate group was performed in 1 time
frame of 30 min.
SPECT reconstruction
U-SPECT-II reconstruction software version 2.38
(MiLabs, Utrecht, The Netherlands) was used to recon-
struct images [23]. 99mTc images were reconstructed by
selecting the photopeak (PP) and background (BG) win-
dows. We used a PP window of 126–154 KeV and BG
windows of 115–120 and 190–200 KeV.
SPECT quantification
To allow quantification of radiotracer uptake in vivo,
conversion factors (CFs) were determined for the
1.0 mm collimator system in a representative phantom
(20 ml) for 99mTc. During the SPECT reconstruction, the
total amount of counts was distributed over the different
voxels, resulting in a counts/voxel expression for the
average concentration of counts. Taking into account,
the voxel volume (Vv) and the CFs are calculated using
Eq. (1):




SPECT counts per voxel
Vv mlð Þ
ð1Þ
Using this formula, we were able to determine the fol-
lowing CF: CFTc = 640 MBq.
Using the PMOD 2.95 view tool (PMOD Technolo-
gies, Zürich, Switzerland), volumes of interest (VOIs)
were drawn in the lower, upper part of the hind limb
(i.e., the area of collateralization). Each VOI had a vol-
ume of 27 mm3. For both the 99mTc-sestamibi and
99mTc-PyP images, the uptake was measured for each
VOI and expressed as mean standardized uptake value
(SUVmean) using Eq. (2).
SUV ¼ SPECT counts per ml  CF½ 
 MBq=mlð Þ  Body weight gð Þ
Injected dose MBqð Þ
 
ð2Þ
For body weight, we assumed that 1 g of body weight
equalled 1 ml.
Histology
A group of 11 C57Bl/6 mice was used solely for histo-
logical purposes at follow-up of 0, 3, 7, or 14 days with
n = 2, 3, 3, and 3, respectively. After euthanasia, tissues
were harvested and prepared for histological examin-
ation of paraffin sections.
α-Smooth muscle actin (αSMA)
Tissue sections (5 μm) were routinely stained for αSMA
and CD68. In short, tissue sections for the αSMA stain-
ing were deparaffinized in xylene, rehydrated in ethanol,
and rinsed in distilled water. Endogenous peroxidases
were blocked in 0.3 % hydrogen peroxide in PBS. Subse-
quently, slides were incubated overnight with the 1A4
anti-smooth muscle actin antibody (Sigma-Aldrich,
Zwijndrecht, The Netherlands) in a dilution of 1:3000.
On the following day, the slides were incubated with the
peroxidase-conjugated rat anti-mouse secondary anti-
body (dilution 1:250), and sites of SMA expression were
visualized by chromogenic detection via 3,3′-diamino-
benzidine (DAB) (DAKO, Heverlee, Belgium) in a dilu-
tion of 1:50. Finally, after dehydration, slides were
mounted using Entellan mounting medium (Merck,
Darmstadt, Germany). Photomicrographs were acquired
using StereoInvestigator software (MBF Bioscience, Will-
iston, USA) on a BX51WI spinning disk confocal fluor-
escence microscope (Olympus, Tokyo, Japan) with a
QIcam color camera (QImaging, Surrey, Canada). In
every tissue specimen, the diameter of five collateral ar-
teries was determined using ImageJ (NIH).
Table 1 Overview of the average LDPI ratios ischemic/non-
ischemic limb in the 99mTc-sestamibi and 99mTc-PyP scanned
group per time point
LDPI
99mTc-sestamibi group
Time point Ratio ± SEM p value N
Baseline 0.98 ± 0.039 NS 7
Post-operatively 0.02 ± 0.004 p < 0.001 7
Day 3 0.10 ± 0.023 p < 0.001 7
Day 7 0.19 ± 0.035 p < 0.001 7
Day 14 0.22 ± 0.016 p < 0.001 7
99mTc-PyP group
Time point Ratio ± SEM p value N
Baseline 1.00 ± 0.015 NS 6
Post-operatively 0.02 ± 0.002 p < 0.001 6
Day 3 0.10 ± 0.006 p < 0.001 6
Day 7 0.19 ± 0.008 p < 0.001 5
Day 14 0.25 ± 0.022 p < 0.001 5
Represented p values indicate the difference compared to the
non-ischemic limb
NS non-significant, N the number of animals available for analysis
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CD68
After rehydration, transversal tissue sections were
blocked in 0.3 % hydrogen peroxide in PBS and 2 % bo-
vine serum albumin in PBS/0.05 % Tween. Non-specific
binding of the avidin/biotin system was prevented using
the avidin/biotin blocking kit (Vector Laboratories, Bur-
lingame, USA). Subsequently, slides were incubated
overnight with the anti-CD68 antibody (Bio-Connect,
Huissen, The Netherlands) in a 1:400 dilution. The fol-
lowing day, in successive order, slides were incubated
with secondary antibody (1:200 dilution), the avidin/bio-
tin complex (Vectastain ABC kit, Vector Laboratories,
Burlingame, USA) (dilution 1:100) and DAB (dilution
1:50) for visualization. Slides were mounted using Entel-
lan mounting medium (Merck, Darmstadt, Germany).
Photomicrographs were acquired using StereoInvestiga-
tor software (MBF Bioscience, Williston, USA) on a
BX51WI spinning disk confocal fluorescence microscope
(Olympus, Tokyo, Japan) with a QIcam color camera
(QImaging, Surrey, Canada). Counting CD68 positive
cells in the peri-muscular fascia was performed using
ImageJ (NIH).
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL)
After rehydration, transverse tissue sections were incu-
bated with proteinase K (20 μg/ml in PBS). After wash-
ing in PBS, tissue sections were blocked in 20 % fetal
bovine serum/3 % bovine serum albumin in PBS.
Double- and single-stranded DNA breaks were subse-
quently enzymatically labeled with fluorescein-dUTP
using the in situ cell death detection kit (Roche,
Mannheim, Germany) according to manufacturer guide-
lines. After washing in PBS, the slides were mounted
using glycerol mounting medium with 4′,6-diamidino-2-
phenylindole (DAPI) and 1,4-diazabicyclo 2,2,2 octane
(DABCO) (Abcam, Cambridge, UK). Photomicrographs
were acquired using Leica application suite X software
(Leica microsystems, Eindhoven, The Netherlands) on a
microscope coupled to a computerized morphometry
Fig. 2 A typical representation of perfusion recovery as seen by 99mTc-sestamibi SPECT and muscular damage as seen by 99mTc-PyP SPECT. In all
images, the lower part of the body is displayed in supine position. Image signal intensity is color-coded and relative to the injected dose per
animal. Asterisk marks the ligated hind limb.
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system (Quantimed 570, Leica, Eindhoven, The
Netherlands). Counting TUNEL positive cells in the
peri-muscular fascia was performed using ImageJ (NIH).
Statistics
Data were expressed as averages for each group ± stand-
ard error of the mean (SEM). Student’s T test was per-
formed to test for the significance between ischemic and
non-ischemic control data. A two-way analysis of vari-
ance (ANOVA) with a Bonferroni post-test was used to
test for significant differences in collateral artery size,
CD68 positivity, and TUNEL positivity in the adductor
muscles between ischemic and non-ischemic limbs. p <
0.05 was considered statistically significant. Data were
analyzed in GraphPad (GraphPad software, La Jolla,
USA).
Results
LDPI post femoral artery ligation
Figure 1 illustrates the typical representation of perfu-
sion recovery as seen on LDPI. Following femoral artery
ligation, average perfusion ratios immediately dropped
to ~2 % of average baseline ratios. Subsequent perfusion
recovery as measured over time by LDPI did not differ
between the two groups (Fig. 3a and Table 1).
SPECT imaging post femoral artery ligation
To study the perfusion recovery and (clearance of ) mus-
cular damage in the total volume of the ischemic versus
the contralateral non-ischemic hind limb, we performed
quantitative SPECT scans on both groups of mice. In
Fig. 2, the perfusion recovery and muscular damage as
seen on SPECT images is illustrated. In the 99mTc-sesta-
mibi scanned group, average SUVs in the ischemic hind
limb dropped significantly compared to the contralateral
non-ischemic hind limb directly after ligation (ratio 0.54
with p = 0.007) and remained decreased 3 days post
ligation (ratio 0.50 with p = 0.006) (Table 2 and Fig. 3b).
Remarkably, 7 and 14 days post ligation surgery average
SUVs indicated nearly full perfusion recovery (Table 2
and Fig. 3b).
Average SUVs obtained from 99mTc-PyP SPECT scans
showed a different course, probably reflecting uptake of
the tracer by damaged skeletal muscle cells. The uptake
of 99mTc-PyP in the ischemic limb increased drastically
upon ligation and peaked 3 days post ligation surgery
(ratio 4.93 with p = 0.004) (Table 2 and Fig. 3c). At day 7
post ligation, average SUVs in the ischemic hind limb
strongly decreased (ratio 3.27 with p = 0.013). The aver-
age ratio continued to decrease and reached a value
comparable to baseline 14 days post ligation (Table 2
and Fig. 3c).
Postmortem analysis of collateral artery size, macrophage
infiltration, and DNA fragmentation
To evaluate post femoral artery ligation changes in col-
lateral artery size in harvested adductor muscles, we
stained for αSMA (Fig. 4a, b). We found a significant in-
crease in mean collateral artery diameter at day 7 and
day 14 post ligation while collateral artery diameter of
the contralateral control limb remained stable over time
(Fig. 4c).
To assess (clearance of ) muscular damage in the ad-
ductor muscle of the ischemic hind limb, a CD68 mono-
cyte/macrophage staining was performed (Fig. 5a, b).
Peak macrophage infiltration in the peri-muscular fascia
in the adductor muscle of the ischemic limb was ob-
served at day 3 post ligation with numbers significantly
higher compared to the non-ischemic limb. Macrophage
infiltration decreased strongly at day 7 after ligation and
remained decreased at day 14 after ligation. ANOVA
analysis revealed no significant differences in CD68
Table 2 Overview of the average SUVs (±SEM) in the non-
ischemic and ischemic hind limb and the average ratio (±SEM)
calculated from SPECT scans in the 99mTc-sestamibi and 99mTc-
PyP group per time point
SPECT
99mTc-sestamibi group












0.27 ± 0.04 0.16 ± 0.04 0.54 ±
0.10
p = 0.007 7
Day 3 0.24 ± 0.04 0.13 ± 0.04 0.50 ±
0.11
p = 0.006 6
Day 7 0.30 ± 0.04 0.28 ± 0.04 0.93 ±
0.10
NS 7
Day 14 0.26 ± 0.04 0.21 ± 0.04 0.81 ±
0.05
p = 0.022 7
99mTc-PyP group
Time point SUV non-
ischemic
SUV ischemic Ratio p value N





0.15 ± 0.04 0.35 ± 0.17 3.08 ±
1.50
NS 6
Day 3 0.16 ± 0.04 0.57 ± 0.08 4.93 ±
1.25
p = 0.004 5
Day 7 0.13 ± 0.04 0.42 ± 0.10 3.27 ±
0.19
p = 0.013 5
Day 14 0.16 ± 0.07 0.18 ± 0.06 1.21 ±
0.21
NS 3
Represented p values indicate the difference compared to the
non-ischemic limb
NS non-significant, N the number of animals available for analysis
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positivity at day 7 and 14 after ligation between ischemic
and non-ischemic limbs (Fig. 5c).
To further assess muscular damage in the adductor
muscle of the ischemic hind limb, we performed a
TUNEL staining (Fig. 6a, b). The TUNEL positivity in
the peri-muscular fascia of the ischemic limb followed a
similar trend compared to the 99mTc-PyP uptake. Post-
operatively, TUNEL positivity was non-significantly in-
creased in the ischemic limb compared to the control
limb, while 3 days after ligation surgery, we observed a
significant increase in TUNEL positivity (p < 0.001) in
the ischemic limb. On day 7 and 14, TUNEL positivity
decreased again to non-significant levels compared to
the control limb (Fig. 6c).
Discussion
This study demonstrates that perfusion recovery as
assessed by 99mTc-sestamibi SPECT appears much faster
than LDPI data suggest. The therapeutic window in an
ischemic hind limb model for the induction of arterio-
genesis might therefore be drastically shorter than indi-
cated by standard LDPI analysis.
Perfusion recovery analysis using nuclear imaging has
previously been investigated in a hind limb ischemia
model in rats [15] and mice [13]. While these studies
used a single time point to indicate perfusion recovery,
they succeeded to show that the scintigraphic enhance-
ment of perfusion was accompanied by morphological
changes (histology) and increased vascularity (angiog-
raphy) indicating ongoing perfusion recovery [13, 15]. In
this study, we subjected two groups of mice to LDPI and
SPECT scans to assess perfusion recovery at five differ-
ent time points: baseline, post-operatively, day 3, 7, and
14, thereby providing a unique insight into the temporal
changes in perfusion recovery throughout the depth of
the limb. Using LDPI, we found an ongoing recovery in
Fig. 3 Average LDPI ratios (ischemic/non-ischemic) of both groups, n = 7 in the 99mTc-sestamibi group, n ≥ 5 in the 99mTc-PyP group (a). Average
ratios determined from SUVs calculated in the 99mTc-sestamibi scanned group with n ≥ 6 for every time point (b). Average ratios determined
from SUVs calculated in the 99mTc-PyP scanned group with n≥ 3 for every time point (c). All data are represented as mean ± SEM. Asterisk
indicates significantly different from non-ischemic in the 99mTc-sestamibi group while number sign is used for significantly different from
non-ischemic in the 99mTc-PyP group
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perfusion 14 days post ligation of the femoral artery,
while the 99mTc-sestamibi SPECT data show nearly
complete recovery of blood perfusion 7 days after
ligation. Additionally, these findings were supported by
postmortem histological analysis. In harvested adductor
muscle tissue, we found a significantly increased collat-
eral artery diameter at day 7 and 14 post ligation.
LDPI and SPECT measure different physiological pa-
rameters. LDPI measures blood velocity whereas 99mTc-
sestamibi SPECT imaging detects steady state distribu-
tion of 99mTc-sestamibi and is therefore a representation
of present blood volume and perfusion through uptake
of the tracer by living and perfused cells. Hence, regard-
less of the low flow velocity, perfused collaterals will be
detected by 99mTc-sestamibi SPECT scans while LDPI
might overlook or underestimate this perfusion. More-
over, 99mTc-sestamibi SPECT imaging is able to indicate
the perfusion over the entire volume of the hind limb
whereas LDPI only reaches a tissue depth of a few
hundred micrometers [8]. The former is obviously pre-
ferred as the majority of perfusion recovery occurs
subcutaneously.
Additionally, skin and muscle perfusion are differently
regulated and perhaps react differently to ligation-induced
ischemia. Beta-2 (β2) adrenergic receptors residing on
muscular arterioles cause vasodilation in response to sym-
pathetic nervous-induced norepinephrine release while
alpha-1 and alpha-2 adrenergic receptors on cutaneous ar-
terioles cause vasoconstriction. A close correlation be-
tween sympathetic activation (causing norepinephrine
release) and myocardial ischemia has already been shown
[24, 25]. Considering the discrepancy between the LDPI
and SPECT data, it is conceivable that ligation-induced is-
chemia triggers the sympathetic nervous system to release
norepinephrine, subsequently causing cutaneous vasocon-
striction and thereby creating an apparent delay in reper-
fusion on LDPI.
The 99mTc-PyP SPECT data showed peak muscular
damage 3 days post ligation and a drastic decrease in
uptake 7 days after ligation. Fourteen days post ligation,
99mTc-PyP SPECT data showed a nearly complete recov-
ery. The increase in uptake of 99mTc-PyP is likely to
come from its binding to hydroxyapatite crystals in dam-
aged myocytes as well as its uptake in macrophages co-
ordinating the clearance of damaged tissue. In support
of this theory and our 99mTc-PyP SPECT data, we found
peak macrophage infiltration in the peri-muscular fascia
in the adductor muscle of the ischemic hind limb at day
3 post ligation. Macrophage numbers continued to de-
crease after the peak at day 3 in the ischemic hind limb
Fig. 4 Increasing collateral diameter over time in ischemic adductor muscles. Representative pictures of collateral arteries are shown immediately
after ligation (a) and at day 14 post ligation (b). Compared to the non-ischemic limb, a significant increase in collateral diameter was found at
day 7 and 14 post ligation (c)
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thereby explaining the decrease in uptake of 99mTc-PyP.
The rapid clearance of muscular damage after peak levels
on day 3 was further underlined by data obtained from
our TUNEL staining. TUNEL positivity in the adductor
muscle of the ischemic limb followed a similar trend as
the 99mTc-PyP uptake. We observed a significantly higher
TUNEL positivity in the ischemic limb compared to the
non-ischemic limb on day 3 after ligation. TUNEL positiv-
ity on day 7 and 14 after ligation were non-significantly
different compared to the non-ischemic limb. Interest-
ingly, uptake of 99mTc-sestamibi roughly mirrored 99mTc-
PyP uptake. This indicates that the lowest level of perfu-
sion coincides with the highest level of muscular damage.
Furthermore, our data show that the (near) completion of
perfusion recovery precedes clearance of damaged myo-
cytes and subsequent muscular recovery.
So far, extremity ischemia and subsequent
neovascularization-guided perfusion recovery in animal
models has often been evaluated by predominantly
anatomic (MRI), invasive (angiography), or limited
(LDPI) techniques. Moreover, accurate documentation
of tissue ischemia and perfusion recovery by means of
histology requires the collection, and often the destruc-
tion of tissue samples, thereby providing limited clinical
relevance and prohibiting serial monitoring of the bio-
logic processes in living animals [26]. Nuclear perfusion
and myocyte damage imaging might provide a useful
and non-invasive alternative to evaluate serial changes in
tissue perfusion. The feasibility and accuracy of nuclear
perfusion imaging has already been demonstrated by
Stacy et al. in a pig model of limb ischemia [27].
The benefit of perfusion imaging in the clinic using
SPECT has already been proven. 99mTc-sestamibi im-
aging in patients has revealed improved sensitivity for
detecting differences in resting perfusion between the
lower extremities of peripheral vascular disease patients
with unilateral disease and improved sensitivity com-
pared with Doppler ultrasound for the detection of
Fig. 5 Monocyte/macrophage infiltration in the peri-muscular fascia over time. Panel a (non-ischemic) and b (ischemic) show representative
images of the CD68 staining 3 days after ligation surgery. Significantly higher macrophage infiltration compared to the non-ischemic limb was
found on day 3 (p < 0.001) (c). On all other days, no significant difference was found
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peripheral vascular disease [28, 29]. Moreover, 99mTc-
sestamibi was also used for the evaluation of regional
blood supply of the thigh and calf muscles in early stages
of atherosclerosis [30, 31]. A reduced stress and rest per-
fusion of the lower limb muscles could be documented
in clinically asymptomatic patients with atherosclerotic
changes of lower limb vessels. Therefore, this technique
could help early detection of the ischemic changes in
asymptomatic patients, thereby enabling early interven-
tion and prevention of disease progression.
Furthermore, 99mTc-PyP has been used to estimate the
ischemic skeletal muscle mass in ischemia-reperfusion
injury [32]. In another study, 99mTc-PyP SPECT was
employed to measure the amount of regional skeletal
muscle necrosis in patients [33]. It was speculated that
the volume of necrosis determined by this method could
predict the clinical outcome.
Our SPECT data shed a new light on studies relying on
LDPI results as a read out parameter to indicate a thera-
peutic effect or window. The LDPI data we obtained largely
resemble those reported in other studies [10, 34] and there-
fore point toward a similar course of perfusion recovery.
However, the presented SPECT data, validated with post-
mortem tissue analysis, indicate recovered perfusion only
7 days post-operatively and clearance of muscular damage
14 days post-operatively.
Conclusions
In conclusion, in this study, we showed that LDPI strongly
overestimates the created therapeutic window in the ische-
mic hind limb model. Overestimation of the therapeutic
window might lead to misinterpretation of the effect of
arteriogenesis stimulating agents or application at the
wrong time point as relevant perfusion recovery might have
already taken place while LDPI still indicates the need for
perfusion improvement. Future studies testing neovascular-
ization stimulating agents in a hind limb model for pro-
found ischemia should take into account that the window
of opportunity is short and that this window can be ascer-
tained using molecular perfusion/myocyte damage tracers
like 99mTc-sestamibi and/or 99mTc-PyP.
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